ライフサイエンスコーパス: mass vaccination

1 the development of vaccines that allow rapid mass vaccination.

2 nted more cases per dose of vaccine than did mass vaccination.

3 eted vaccination increased more than that of mass vaccination.

4 ed with these estimates of R(0) suggest that mass vaccination against cholera deployed strategically

5 e of clinical and cosmetic uses of BoNT make mass vaccination against the toxin undesirable and impra

6 Mass vaccination allows us to study how immunity operate

7 y of LAIVs should be closely monitored after mass vaccination and that novel strategies to continue t

8 exclusion and coexistence of serotypes under mass vaccination are derived, and the equilibrium carria

9 The arguments against mass vaccination are that the effectiveness of BCG in pr

10 argeted vaccination be more competitive with mass vaccination at both preventing and containing a del

11 of protection provided by MenB-4C following mass vaccination at regional level.

12 ity to control dog populations and implement mass vaccination because of financial, logistical and ot

13 Mass vaccination before smallpox introduction or immedia

14 e were offered oral cholera vaccine during a mass vaccination campaign between March 30 and April 30,

15 population immunity to measles virus after a mass vaccination campaign in a region with high HIV prev

16 Following a mass vaccination campaign of all persons 1-29 years of a

17 e successful introduction of MenAfriVac in a mass vaccination campaign targeting 1- to 29-year-olds i

18 ates; 2) predict the effect of the influenza mass vaccination campaign that began in October 2009 on

19 In efforts to control this epidemic, a mass vaccination campaign was held in April 1995.

20 010, Africa's first preventive meningococcal mass vaccination campaign was launched using a newly dev

21 During a mass vaccination campaign, adults at a clinic in Odessa

22 age groups up to 2 years after Mali's PsA-TT mass vaccination campaign.

23 We also explain recent changes in mass vaccination campaigns against HPV and the potential

24 ic of H1N1 influenza virus in China and with mass vaccination campaigns against influenza during the

25 Mass vaccination campaigns can be successful in vaccinat

26 e modeled vaccination strategy is to conduct mass vaccination campaigns every 5 years for children 1-

27 Follow-up mass vaccination campaigns for children younger than 5 y

28 easured in 254 children before and after two mass vaccination campaigns in Jordan.

29 Current mass vaccination campaigns in measles outbreak response

30 Following mass vaccination campaigns in the African meningitis bel

31 een substantial funding for large preventive mass vaccination campaigns in the most affected countrie

32 the efficacy of meningococcal vaccine during mass vaccination campaigns in US civilian populations ha

33 s (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1-29-year-olds in Burkina

34 Mass vaccination campaigns of the population aged 1-29 y

35 to define priority geographical areas where mass vaccination campaigns should be conducted.

36 The implementation of mass vaccination campaigns targeting women of childbeari

37 Supplementing these activities with mass vaccination campaigns triggered when low levels of

38 The impact of the recent mass vaccination campaigns was assessed by evaluating th

39 r of people who received the vaccine through mass vaccination campaigns was several hundredfold highe

40 Mass vaccination campaigns with parenteral vaccines, and

41 Mass vaccination campaigns with the oral poliovirus vacc

42 ill require new delivery strategies, such as mass vaccination campaigns, and new products targeted at

43 an would support evidence-based planning for mass vaccination campaigns.

44 data are commonly used to assess coverage of mass vaccination campaigns.

45 al tool for facilitating inexpensive IPV for mass vaccination campaigns.

46 Moreover, in certain cases mass vaccination can have the counterproductive effect o

47 A short mass vaccination catch-up campaign, not yet in the portf

48 China-the world's largest population-in the mass vaccination era remains poorly understood.

49 Comparing the results to mass vaccination from the moment an attack is recognized

50 nough rate to justify the discontinuation of mass vaccination from this perspective.

51 human influenza, such potential benefits of mass vaccination have so far proved elusive.

52 ial of live att avian influenza vaccines for mass vaccination in poultry.

53 it is optimal to target children for dengue mass vaccination in Thailand, whereas young adults shoul

54 RMHC is up to 84% more effective than random mass vaccination in the mid range of vaccine availabilit

55 lion population), whereas in regions without mass vaccination, incidence was 43.8 per 100,000 (3809 c

56 he effectiveness of postrelease targeted and mass vaccinations increased if we assumed that there was

57 valent vaccination programme was the largest mass vaccination initiative in recent US history.

58 Mass vaccination is the primary element of the public he

59 Despite mass vaccination, it remains a leading cause of death in

60 ccines target adults, although high-coverage mass vaccinations may be logistically more challenging a

61 ed with early detection without resorting to mass vaccination of a population.

62 interruption of rubella transmission through mass vaccination of adolescents and adults, and strength

63 Biannual mass vaccination of cattle leaves significant immunity g

64 Consequently, mass vaccination of cattle with v2RVFH could eradicate r

65 (FMD) in Turkey is controlled using biannual mass vaccination of cattle.

66 ealth approach to rabies control through the mass vaccination of dogs and control of canine populatio

67 atches may provide an innovative approach to mass vaccination of dogs.

68 Widespread mass vaccination of domestic dogs reduced the probabilit

69 ing implementation of the current policy for mass vaccination of women of childbearing age an urgent

70 ing with traced vaccination and switching to mass vaccination only if required.

71 d provide a better response to bioterrorism, mass vaccination, or vaccination of social contacts, so-

72 opulation from 3 weeks up to 13 months after mass vaccination (P = .003).

73 r combination mass drug administration and a mass vaccination program approach to eliminate malaria f

74 ntial to minimize program costs and increase mass vaccination program feasibility.

75 Their concomitant critical importance in mass vaccination programmes may have prompted recent int

76 Despite mass vaccination, reported pertussis cases have increase

77 moment an attack is recognized, we find that mass vaccination results in both far fewer deaths and mu

78 n which hepatitis A is endemic, and/or under mass-vaccination scenarios.

79 cluding those believed most likely, and that mass vaccination similarly outperforms the existing poli

80 ve profound implications for a transition to mass vaccination strategies against human influenza, and

81 od would be a value as a potential universal mass vaccination strategy.

82 e the potential counterproductive effects of mass vaccination, through compensating for losses in nat

83 he best response to the most likely outcome, mass vaccination thus has the advantage of preventing ou

84 Universal mass vaccination (UMV) has been shown to prevent the bur

85 communities to compare the effectiveness of mass vaccination versus targeted vaccination of close co

86 ulosis control, but the expected benefits of mass vaccination will be eroded if strain replacement wi

87 , supplementation of preemptive therapy with mass vaccination will become a cost-effective option.

88 Assuming biannual mass vaccination with a single-dose primary course, vacc

89 In 2010, mass vaccination with a then-new meningococcal A polysac

90 A fell from 0.7% to 0.02% in Chad following mass vaccination with MenAfriVac.

91 these approaches is currently being used for mass vaccination (with the exception or vaccinia-rabies

92 there is also a substantial probability that mass vaccination would save 200,000 or more lives than t

93 le scenario, the most likely outcome is that mass vaccination would save approximately 100,000 more l